SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-22-206626
Filing Date
2022-07-29
Accepted
2022-07-29 16:11:45
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3 d346125df3.htm F-3 514938
2 EX-1.2 d346125dex12.htm EX-1.2 201123
3 EX-5.1 d346125dex51.htm EX-5.1 27066
4 EX-23.1 d346125dex231.htm EX-23.1 1864
5 EX-FILING FEES d346125dexfilingfees.htm EX-FILING FEES 23995
6 GRAPHIC g346125g02j66.jpg GRAPHIC 46487
  Complete submission text file 0001193125-22-206626.txt   830555
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-266404 | Film No.: 221120927
SIC: 2836 Biological Products, (No Diagnostic Substances)